« Back to Record
Oakman, C., Di Leo, A., Francis, P., Crown, J., Quinaux, E., Buyse, M., de Azambuja, E., Punzalan, L., Piccart-Gebhart, M., Vila, M. M., Andersson, M., Nordenskjöld, B., Jakesz, R., Thürlimann, B., Gutiérrez, J. M. J., Harvey, V., Dell'Orto, P., Viale, G., Larsimont, D., Steinberg, I., & Gelber, R. (2013). Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer-8-year results of the breast international group 02-98 phase III trial. Annals of oncology, 24(5), mds627, 1203-1211. doi:10.1093/annonc/mds627
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/183186



